Literature DB >> 10849253

Ochratoxin A from a toxicological perspective.

E Petzinger1, K Ziegler.   

Abstract

Ochratoxin A (OTA) is a widespread mycotoxin which is produced mainly by the mould fungi Aspergillus ochraceus and Penicillum verrucosum during the storage of cereals, cereal products and other plant-derived products such as herbs, spices, grapes, etc. By carry over from mouldy fodder, ochratoxin A is also found in pork meat, offal and sausages containing pork blood. When ingested as a food contaminant, OTA is very persistent in human beings with a blood half-life of 35 days after a single oral dosage due to unfavourable elimination toxicokinetics. This renders the toxin among the most frequent mycotoxin contaminants in human blood in the EU, the US, Canada, and elsewhere, where it has been investigated. OTA is neither stored nor deposited in the body, but heterogeneous body distribution may impose serious damage to the kidneys. The toxin was classified a 2B cancer compound, being possibly carcinogenic for humans. It was among the strongest carcinogenic compounds in rats and mice. As the toxicological profile also includes teratogenesis, nephrotoxicity, and immunotoxicity, legislation authorities are currently discussing maximal residue levels (MRL) for OTA in various foodstuffs. In the present article arguments are presented which suggest an acceptable daily intake (ADI) of 1.5 ng OTA/kg body weight and a much lower MRL than 5 microgram OTA/kg cereals and cereal products as has been postulated by the EU commission.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849253     DOI: 10.1046/j.1365-2885.2000.00244.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  50 in total

1.  A fluorescent aptasensor for ochratoxin A detection based on enzymatically generated copper nanoparticles with a polythymine scaffold.

Authors:  Yue He; Fengyu Tian; Jing Zhou; Bining Jiao
Journal:  Mikrochim Acta       Date:  2019-02-22       Impact factor: 5.833

2.  Phylogenetic analysis of polyketide synthase genes fromAspergillus ochraceus.

Authors:  J O'Callaghan; A D W Dobson
Journal:  Mycotoxin Res       Date:  2006-06       Impact factor: 3.833

3.  Genetic background of ochratoxin A production inPenicillium.

Authors:  A Karolewiez; C Bogs; R Geisen
Journal:  Mycotoxin Res       Date:  2005-03       Impact factor: 3.833

4.  Mycobiota and mycotoxins in Portuguese pork, goat and sheep dry-cured hams.

Authors:  Paula Rodrigues; Diana Silva; Pedro Costa; Luís Abrunhosa; Armando Venâncio; Alfredo Teixeira
Journal:  Mycotoxin Res       Date:  2019-09-08       Impact factor: 3.833

5.  Inhibition of ochratoxin A production and growth of Aspergillus species by phenolic antioxidant compounds.

Authors:  Jeffrey D Palumbo; Teresa L O'Keeffe; Noreen E Mahoney
Journal:  Mycopathologia       Date:  2007-09-12       Impact factor: 2.574

6.  Screening and Optimization of Newly Isolated Thermotolerant Lysinibacillus fusiformis Strain SK for Protease and Antifungal Activity.

Authors:  Sujan Khadka; Sanjib Adhikari; Alina Thapa; Raju Panday; Manjila Adhikari; Sanjeep Sapkota; Ramesh Sharma Regmi; Namita Paudel Adhikari; Ram Proshad; Niranjan Koirala
Journal:  Curr Microbiol       Date:  2020-04-04       Impact factor: 2.188

7.  Ochratoxin A induces apoptosis in neuronal cells.

Authors:  Xiangnan Zhang; Christine Boesch-Saadatmandi; Yijia Lou; Siegfried Wolffram; Patricia Huebbe; Gerald Rimbach
Journal:  Genes Nutr       Date:  2009-01-16       Impact factor: 5.523

8.  Silibinin pretreatment protects against ochratoxin A-mediated apoptosis in primary rat hepatocytes.

Authors:  E Essid; E Petzinger
Journal:  Mycotoxin Res       Date:  2011-04-19       Impact factor: 3.833

9.  Species-specific fungal DNA in airborne dust as surrogate for occupational mycotoxin exposure?

Authors:  Anne Straumfors Halstensen
Journal:  Int J Mol Sci       Date:  2008-12-10       Impact factor: 6.208

10.  Survey of slaughtered pigs for occurrence of ochratoxin A and porcine nephropathy in Serbia.

Authors:  Dragan Milićević; Verica Jurić; Srđan Stefanović; Milijan Jovanović; Saša Janković
Journal:  Int J Mol Sci       Date:  2008-11-07       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.